Search

Your search keyword '"Oksanen, Minna"' showing total 247 results

Search Constraints

Start Over You searched for: Author "Oksanen, Minna" Remove constraint Author: "Oksanen, Minna"
247 results on '"Oksanen, Minna"'

Search Results

54. Connecting Secondary Metabolites and Biosynthetic Gene Clusters

55. Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors

57. Analysing Ballistocardiography for Pervasive Healthcare

58. Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease

59. NF‐E2‐related factor 2 activation boosts antioxidant defenses and ameliorates inflammatory and amyloid properties in human Presenilin‐1 mutated Alzheimer's disease astrocytes

60. T-cell Subsets in Peripheral Blood and Tumors of Patients Treated With Oncolytic Adenoviruses

61. This title is unavailable for guests, please login to see more information.

63. NF‐E2‐related factor 2 activation boosts antioxidant defenses and ameliorates inflammatory and amyloid properties in human Presenilin‐1 mutated Alzheimer's disease astrocytes.

64. PPARβ/δ‐agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes

66. Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease

67. Human iPSC-derived neurons and astrocytes as models of neurodegeneration, neuroinflammation and vesicular trafficking in Alzheimer's disease

68. Structural Immaturity of Human iPSC-Derived Cardiomyocytes: In Silico Investigation of Effects on Function and Disease Modeling

70. [P3-170]: HUMAN IPSC-DERIVED ALZHEIMER's DISEASE ASTROCYTES RECAPITULATE DISEASE-RELATED PHENOTYPES

72. Creation of a library of induced pluripotent stem cells from Parkinsonian patients

78. Abstract B51: Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

81. Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Resultsin vitro, in rodents and in humans

84. Huumeet ja äiti-lapsi -suhde : Äidin huumeiden käytön ja vauvan temperamentin yhteys varhaisen vuorovaikutussuhteen laatuun

85. Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy

86. Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment

87. [18F]-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography in Response Evaluation of Oncolytic Adenovirus Treatments of Patients with Advanced Cancer

90. Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus

91. Abstract 3304: Oncolytic adenovirus with low-dose temozolomide induces autophagy and antitumor immune responses preclinically and in cancer patients.

92. CGTG-102 (Ad5/3-D24-GMCSF), a novel oncolytic adenovirus, in patients with refractory solid tumors: Experience from an advanced therapy access program.

93. Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients

94. Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors

95. In vivoandin vitrodistribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments

96. Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients

97. Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors

98. Oncolytic adenovirus treatment of a patient with refractory neuroblastoma

99. Oncolytic adenovirus treatment of a patient with refractory neuroblastoma

Catalog

Books, media, physical & digital resources